Onconova Therapeutics Stock Price - ONTX

-0.0098 (-3.06%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Onconova Therapeutics Inc ONTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.003 -0.93% 0.3199 0.30 0.3199 0.3188 0.3229 00:00:06
Bid Price Ask Price Spread Spread % News
0.30 0.34 0.04 11.76% 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6,167 4,571,428 $ 0.31043 $ 1,419,108 11,359,445 0.1027 - 5.25
Last Trade Time Type Quantity Stock Price Currency
19:59:15 formt 100 $ 0.3101 USD

Onconova Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 44.38M 138.73M $ -20.57M -1.50 - 137.22M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Onconova Therapeutics News

Loading Messages....

Latest ONTX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ONTX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.320.440.29220.344944810,393,364-0.0001-0.03%
1 Month0.410.540.2730.39387049,877,531-0.0901-21.98%
3 Months0.420.7490.2730.46056417,104,996-0.1001-23.83%
6 Months1.061.210.10270.40174414,591,332-0.7401-69.82%
1 Year3.905.250.10270.41377337,316,562-3.58-91.8%
3 Years45.9058.200.10271.872,838,988-45.58-99.3%
5 Years34.80122.550.10272.881,769,814-34.48-99.08%

Onconova Therapeutics Description

Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company operating in the US. It focuses on discovering and developing novel small molecule product candidates primarily to treat cancer. The company has created a library of targeted agents designed to work against cellular pathways important to cancer cells. Its product candidates are Single-agent IV rigosertib, Oral rigosertib + azacitidine, IV Briciclib, Recilisib, and ON 123300. The key product candidate Rigosertib is a small molecule which blocks cellular signaling by targeting RAS effector pathways.

Your Recent History
Onconova T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.